Live Chat
Live Chat

About Us

Share

Share

Scientific Advisory Board

Kenneth Blum, Ph.D.

Kenneth Blum, Ph.D.

Member, RiverMend Health Scientific Advisory Board

Chairman of the Board and Chief Scientific Officer of LifeGen, Inc.
Managing Partner, Reward Deficiency Solutions, LLC
Scientific Director, PATH Foundation
Senior Scientific Advisor for G&G Holistic Addictions Treatment Center

My Clinical Expertise:

  • Alcohol & Psychiatric Genetics
  • Chemical Dependency
  • Psychiatric Genetics
  • Pharmacology

Kenneth Blum, Ph.D. is currently Chairman of the Board and Chief Scientific Officer of LifeGen, Inc. and managing partner of Reward Deficiency Solutions, LLC. He is a retired Professor of Pharmacology at University of Texas, and San Antonio, Texas where he served for 23 years. He is currently Courtesy Professor of the Department of Psychiatry University of Florida College of Medicine. He serves as Scientific Director, PATH Foundation, New York, NY. He is the Senior Scientific Advisor for G&G Holistic Addictions Treatment Center, North Miami Beach, Florida. He is also Research Professor in the Department of Physiology and Pharmacology, Wake Forest College of Medicine.

Dr. Blum has chaired three Gordon Conferences on Alcohol and Psychiatric Genetics. He is the recipient of numerous awards including NIDA Career Teacher Award; American Chemical Society Speakers Award; Gordon Conference Research Award; Presidential Excellence Award (National Council of Alcoholism and Drug Abuse).

Dr. Blum is the author and/or editor of eleven books and has published over 400 peer reviewed papers. He is also executive editor of the Journal Genetics and Genetic Syndromes (Omics Group) and is an ad hoc reviewer for 40 journals worldwide. Dr. Blum is published in almost every major scientific journal worldwide: Science; Lancet; Nature; PNAS, JAMA among others. He is actively investigating the role of natural dopamine agonists as an anti-craving DNA directed therapeutic target for prevention of relapse.

  • Chairman of the Board and Chief Scientific Officer, LifeGen Inc.
  • Managing Partner, Reward Deficiency Solutions, LLC
  • Retired Professor, Pharmacology, University of Texas
  • Courtesy Professor, Department of Psychiatry, University of Florida College of Medicine
  • Scientific Director, PATH Foundation
  • Senior Scientific Advisor, G&G Holistic Addictions Treatment Center
  • Research Professor, Department of Physiology and Pharmacology, Wake Forest College of Medicine
  • Chaired, Gordon Conferences on Alcohol and Psychiatric Genetics
  • Recipient, NIDA Career Teacher Award; American Chemical Society Speakers Award; Gordon Conference Research Award; Presidential Excellence Award
  • Author/Editor, eleven books and over 400 peer reviewed papers
  • Executive Director, Journal Genetics and Genetic Syndromes
  • Currently investigating the role of dopamine agonists as an anti-craving DNA directed therapeutic target for prevention of relapse

Coming Soon

Coming Soon